Gilbert G. Prive
Toronto, ON M5S1A8, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Discovery of pyrrolopyrimidinone inhibitors of the BCL6-SMRT corepressor interaction.
Journal: Bioorganic & medicinal chemistry
Published: December 16, 2025
Derivation and characterization of ubiquitin-specific protease 18 inhibitors.
Journal: JCI insight
Published: December 01, 2025
Structure-based discovery of sulfamoyl-ethyl-4-oxo-3,4-dihydro-7H-pyrrolo[2,3-d]pyrimidine amides and sulfonamides as potent B-Cell Lymphoma 6 (BCL6)-BTB inhibitors.
Journal: Bioorganic & medicinal chemistry letters
Published: October 27, 2025
The E3-ome gene-centric compendium reveals the human E3 ligase landscape.
Journal: Cell
Published: February 16, 2025
Serine phosphorylation facilitates protein degradation by the human mitochondrial ClpXP protease.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 29, 2025
Structure and dynamics of a pentameric KCTD5/CUL3/Gβγ E3 ubiquitin ligase complex.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 16, 2024
Crystal structure of NRAS Q61K with a ligand-induced pocket near switch II.
Journal: European journal of cell biology
Published: January 17, 2024
Discovery of OICR12694: A Novel, Potent, Selective, and Orally Bioavailable BCL6 BTB Inhibitor.
Journal: ACS medicinal chemistry letters
Published: November 30, 2022
The NCOR-HDAC3 co-repressive complex modulates the leukemogenic potential of the transcription factor ERG.
Journal: Nature communications
Published: March 07, 2022
High-Throughput Evaluation of Emission and Structure in Reduced-Dimensional Perovskites.
Journal: ACS central science
Published: January 15, 2022
Structures of RGL1 RAS-Association Domain in Complex with KRAS and the Oncogenic G12V Mutant.
Journal: Journal of molecular biology
Published: September 30, 2021
Last Updated: 09/26/2026